Aditya Birla Sun Life Pharma and Healthcare Fund - Direct Plan - GROWTH
Mutual Fund · Equity Scheme - Sectoral/ Thematic · As of 18 Oct 2026, 6:03 pm
Solid risk-adjusted track record over the available NAV history. Returns have been compensating reasonably for the volatility taken. Still confirm current expense ratio, exit load, and portfolio concentration directly from the AMC factsheet before committing.
DalalBaazaar Score
81/ 100
Strong
Weighted across five categories. Every point is explained below.
✗ Worst peak-to-trough fall was 20.5%. That is the loss you would have had to hold through without selling.
✓ Captured only 26% of the index's down months
• Capture profile: 89% of index gains, 26% of index falls
Investment Checklist
4 / 4 checks passed
✓ Positive 3-year track record
✓ Decent risk-adjusted return (Sharpe ≥ 0.5)
✓ Volatility isn't extreme (< 25% annualized)
✓ Historical worst drawdown contained (better than -30%)
NAV history
Key Metrics
Latest NAV
₹38.01
As of
16 Oct 2026
Fund History Available
7.3 yrs
1Y Return (CAGR)
10.0%
Moderate
3Y Return (CAGR)
18.9%
5Y Return (CAGR)
13.4%
Annualized Volatility
13.0%
Relatively stable
Sharpe Ratio (est.)
0.91
Moderate
Max Drawdown
-20.5%
Notable drop seen
Category
Equity Scheme - Sectoral/ Thematic
Fund House
Aditya Birla Sun Life Mutual Fund
SIP / Lumpsum Calculator
Total Invested
₹6,00,000
Estimated Maturity Value
₹9,61,879
Estimated Gain
₹3,61,879
Watch Items
Check the AMC's factsheet for portfolio holdings, expense ratio and exit load before investing.
